Display options
Cite
Donald M, King-Shier K, Tsuyuki RT, et al. Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study. CMAJ Open. 2017;5(1):E205-E212doi: 10.9778/cmajo.20160135.
Donald, M., King-Shier, K., Tsuyuki, R. T., Al Hamarneh, Y. N., Jones, C. A., Manns, B., Tonelli, M., Tink, W., Scott-Douglas, N., & Hemmelgarn, B. R. (2017). Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study. CMAJ open, 5(1), E205-E212. https://doi.org/10.9778/cmajo.20160135
Donald, Maoliosa, et al. "Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study." CMAJ open vol. 5,1 (2017): E205-E212. doi: https://doi.org/10.9778/cmajo.20160135
Donald M, King-Shier K, Tsuyuki RT, Al Hamarneh YN, Jones CA, Manns B, Tonelli M, Tink W, Scott-Douglas N, Hemmelgarn BR. Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study. CMAJ Open. 2017 Mar 06;5(1):E205-E212. doi: 10.9778/cmajo.20160135. eCollection 2017. PMID: 28401136; PMCID: PMC5378504.
Copy Download .nbib Format: NLM
Share it on

CMAJ Open. 2017 Mar 06;5(1):E205-E212. doi: 10.9778/cmajo.20160135. eCollection 2017.

Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study.

CMAJ open

Maoliosa Donald, Kathryn King-Shier, Ross T Tsuyuki, Yazid N Al Hamarneh, Charlotte A Jones, Braden Manns, Marcello Tonelli, Wendy Tink, Nairne Scott-Douglas, Brenda R Hemmelgarn

Affiliations

  1. Department of Medicine (Donald, Manns, Tonelli, Scott-Douglass, Hemmelgarn); Interdisciplinary Chronic Disease Collaboration (Donald, Manns, Tonelli, Hemmelgarn); Department of Community Health Sciences (King-Shier, Manns, Tonelli, Hemmelgarn); Faculty of Nursing (King-Shier), University of Calgary, Calgary, Alta.; Department of Medicine (Tsuyuki, Al Hamarneh), EPICORE Centre, University of Alberta, Edmonton, Alta.; Southern Medical Program (Jones), University of British Columbia, Kelowna, BC; Department of Family Medicine (Tink), University of Calgary, Calgary, Alta.

PMID: 28401136 PMCID: PMC5378504 DOI: 10.9778/cmajo.20160135

Abstract

BACKGROUND: The RxEACH trial was a randomized trial to evaluate the efficacy of community pharmacy-based case finding and intervention in patients at high risk for cardiovascular (CV) events. Community-dwelling patients with poorly controlled risk factors were identified and their CV risk reduced through patient education, prescribing and follow-up by their pharmacist. Perspectives of patients, family physicians and community pharmacists were obtained regarding pharmacists' identification and management of patients at high risk for CV events, to identify strategies to facilitate implementation of the pharmacist's expanded role in routine patient care.

METHODS: We used a qualitative methodology (individual semistructured interviews) with conventional qualitative content analysis to describe perceptions about community pharmacists' care of patients at high risk for CV events. Perceptions were categorized into macro (structure), meso (institution) and micro (practice) health system levels, based on a conceptual framework of care for optimizing scopes of practice.

RESULTS: We interviewed 48 participants (14 patients, 13 family physicians and 21 community pharmacists). Patients were supportive of the expanded scope of practice of pharmacists. All participant groups emphasized the importance of communication, ability to share patient information, trust and better understanding of the roles, responsibilities, accountabilities and liabilities of the pharmacist within their expanded role.

INTERPRETATION: Despite support from patients and changes to delivery of care in primary care settings, ongoing efforts are needed to understand how to best harmonize family physician and community pharmacist roles across the health system. This will require collaboration and input from professional associations, regulatory bodies, pharmacists, family physicians and patients.

Conflict of interest statement

Competing interests: None declared.

References

  1. CMAJ. 2013 Oct 1;185(14):1228-32 - PubMed
  2. J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):67-71 - PubMed
  3. J Am Coll Cardiol. 2016 Jun 21;67(24):2846-54 - PubMed
  4. Circulation. 2015 Jul 14;132(2):93-100 - PubMed
  5. Can Pharm J (Ott). 2013 Nov;146(6):365-7 - PubMed
  6. Res Social Adm Pharm. 2015 Sep-Oct;11(5):602-22 - PubMed
  7. BMJ Open. 2013 Sep 24;3(9):e003154 - PubMed
  8. Qual Health Res. 2005 Nov;15(9):1277-88 - PubMed
  9. Can Pharm J (Ott). 2016 Jul;149(4):236-45 - PubMed
  10. Adv Health Sci Educ Theory Pract. 2012 May;17(2):247-57 - PubMed
  11. BMC Health Serv Res. 2012 Sep 16;12:320 - PubMed
  12. Can Pharm J (Ott). 2016 Sep;149(5):283-292 - PubMed
  13. Int J Clin Pharm. 2012 Apr;34(2):364-73 - PubMed
  14. Res Nurs Health. 2000 Aug;23(4):334-40 - PubMed
  15. Can Fam Physician. 2009 Dec;55(12):e69-75 - PubMed

Publication Types